These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6342454)

  • 21. Estrogen synthetase. Effect of sulfhydryl reactive reagents on androgen aromatization by human term placental microsomes.
    Bellino FL; Osawa Y
    J Steroid Biochem; 1980 Mar; 13(3):339-44. PubMed ID: 6771467
    [No Abstract]   [Full Text] [Related]  

  • 22. Aromatization of testosterone and 19-nortestosterone by a single enzyme from equine testicular microsomes. Differences from human placental aromatase.
    Silberzahn P; Gaillard JL; Quincey D; Dintinger T; Al-Timimi I
    J Steroid Biochem; 1988 Jan; 29(1):119-25. PubMed ID: 3347045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro conversion of (4-14C) dehydroepiandrosterone and androstenedione to oestrogens by the microsomes of placentas from normal, toxaemic, diabetic and postmature pregnancies.
    Lehmann WD; Lauritzen C; Schumann R
    Acta Endocrinol (Copenh); 1973 Aug; 73(4):771-89. PubMed ID: 4270460
    [No Abstract]   [Full Text] [Related]  

  • 24. Kinetic properties of steroid 19-hydroxylase and estrogen synthetase from porcine ovary microsomes.
    Kautsky MP; Hagerman DD
    J Steroid Biochem; 1980 Nov; 13(11):1283-90. PubMed ID: 7453174
    [No Abstract]   [Full Text] [Related]  

  • 25. Ascorbic acid inhibition of aromatase activity in human placenta tissue.
    Milewich L; Chen GT; MacDonald PC; Peterson JA
    J Steroid Biochem; 1981 Feb; 14(2):185-93. PubMed ID: 7206706
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of androgen aromatization in human breast cancer.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Dec; 13(12):1395-400. PubMed ID: 7464118
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the mechanism of action of the aromatase inhibitor, 4-hydroxyandrostenedione.
    Abul-Hajj YJ
    Steroids; 1983 Jun; 41(6):783-90. PubMed ID: 6665821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human placental aromatase activity: use of a C18 reversed-phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro.
    Pasanen M
    Biol Res Pregnancy Perinatol; 1985; 6(2):94-9. PubMed ID: 4016169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatization of androstenedione to estrogen by human fetal tissues in vitro.
    Yamamoto T; Sakai C; Okada H
    Asia Oceania J Obstet Gynaecol; 1984 Jun; 10(2):241-4. PubMed ID: 6477311
    [No Abstract]   [Full Text] [Related]  

  • 30. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC; Watson DM; So OY
    Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic properties of human placental aromatase. Application of an assay measuring 3H2O release from 1beta,2beta-3H-androgens.
    Reed KC; Ohno S
    J Biol Chem; 1976 Mar; 251(6):1625-31. PubMed ID: 3502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New aromatase assay and its application for inhibitory studies of aminoglutethimide on microsomes of human term placenta.
    Rabe T; Rabe D; Runnebaum B
    J Steroid Biochem; 1982 Sep; 17(3):305-9. PubMed ID: 7132348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human estrogen synthetase (aromatase) by flavones.
    Kellis JT; Vickery LE
    Science; 1984 Sep; 225(4666):1032-4. PubMed ID: 6474163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of aromatization of 19-oxygenated 16 alpha-hydroxyandrostenedione with human placental microsomes by high-performance liquid chromatography coupled with coulometric detection.
    Numazawa M; Konno T; Furihata R; Ishikawa S
    J Steroid Biochem; 1990 Jul; 36(4):369-75. PubMed ID: 2391967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione.
    Thompson EA; Siiteri PK
    J Biol Chem; 1974 Sep; 249(17):5364-72. PubMed ID: 4153532
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
    Covey DF; Hood WF; Beusen DD; Carrell HL
    Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilization of placental aromatase by dithiothreitol in the presence of oxidizing agents.
    Kelly WG; Stolee AH
    Steroids; 1978 Apr; 31(4):533-9. PubMed ID: 663986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
    Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
    Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen synthetase. Demonstration that the high molecular weight form of NADPH-cytochrome C reductase from human placental microsomes is required for androgen aromatization.
    Bellino FL
    J Steroid Biochem; 1982 Sep; 17(3):261-70. PubMed ID: 6813599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.